# Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety

> **NCT02586363** · PHASE1 · UNKNOWN · sponsor: **Seoul St. Mary's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Baraclude Tab. 0.5mg, fasting
- **DRUG:** Cavir Tab. 0.5mg, fasting
- **DRUG:** Cavir Tab. 0.5mg, high fatty meal

## Key facts

- **NCT ID:** NCT02586363
- **Lead sponsor:** Seoul St. Mary's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2015-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02586363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02586363, "Study of Evaluation of Cavir Tab. 0.5mg With Food Effect on Pharmacokinetics and Safety". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02586363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*